1. Introduction {#sec1}
===============

Human rhinoviruses (HRVs) are common agents of human infections \[[@B1]\]. Due to their similar genomic organization, they are classified within the same family *Picornaviridae* together with the human enteroviruses (HEV) \[[@B2], [@B3]\]. However, the common genomic features reflect modestly the characteristics of these viruses in terms of tropism and pathogenic potential. HRVs generally cause mild infections, replicating in the upper respiratory tract, but, in infants and immunocompromised patients, HRVs can reach the lower respiratory tract causing serious illnesses and act as pathogens or copathogens in bronchitis, bronchiolitis, and pneumonia \[[@B4], [@B5]\]. Recently a new HRV lineage designated HRV-C has been identified using molecular methods and associated with severe clinical presentations in infants and immunocompromised adults \[[@B6]\]. The majority of HEVs instead replicate in the gastrointestinal tract, eventually spreading to other organs such as the heart or the central nervous system giving rise to serious diseases. Only a few HEV genotypes can occasionally be identified in the respiratory secretions of patients with lower respiratory tract infections \[[@B5], [@B7]\]. Moreover, a novel HEV (HEV 104) was identified in Switzerland and later in other countries often in association with respiratory signs \[[@B7], [@B8]\]. Finally, a novel HEV (HEV 109) was molecularly identified in the nose and throat swab samples collected between June 2007 and June 2008 from children enrolled in a cohort study of influenza-like illness in Nicaragua, in some cases also associated with enteric symptoms \[[@B9]\].

In the present study, the prevalence and persistence and the pathogenic potential of HRVs were retrospectively evaluated by molecular analysis and phylogenetic reconstruction in sequential nasopharyngeal aspirates obtained from immunosuppressed hematopoietic stem cell transplantation adult recipients. In the same cohort the presence of other coinfecting respiratory pathogens, including the novel HEV 109, was also evaluated.

2. Methods {#sec2}
==========

A total of 175 archived respiratory samples (nasopharyngeal aspirates) were obtained from 50 allogeneic and 4 autologous haematopoietic stem cell transplant recipient patients recruited at the Division of Hematology, IRCCS Policlinico San Matteo (Pavia, Italy) regardless of respiratory symptoms, as described \[[@B10], [@B11]\]. Respiratory samples were consecutively obtained after informed consent from October 1st, 2004 to April 2007. From one to nine samples from each patient were collected every 30 days up to 180 days after transplantation. At each time point all the clinical data were collected. RNA was purified from all samples using the Qiagen RNA mini kit (Qiagen, Germany) following the manufacturer protocol. To investigate HRV infections, all samples, were subjected to first round amplification after sample extraction using Primers P1-1 (CAA GCA CTT CTG TYW CCC C) and P3-1 (ACG GAC ACC CAA AGT AG); and semi-nested amplification was performed using forward primer P1-1 and three reversed primers P2-1 (CAA GCA CTT CTG TYW CCC C), P2-2 (TTA GCC ACA TTC AGG AGC C) and P2-3 (TTA GCC GCA TTC AGG GG) as described previously \[[@B12]\]. Since HEV 109 was initially cross-amplified also with the previous amplification protocol (designed to amplify the widest number of Picornaviruses), we decided to further evaluate HEV 109 prevalence by using specific primers targeting the NTR region of HEV 109 (EV109 VP1 123F, 5′-GGA GAC TGG AGC AAC TAG TAA AG-3′; EV109 VP1 363R, 5′-GGT GAA CAT TTC CAA TTT CCT ACG-3′).

All the amplification products were sequenced bidirectionally to confirm amplification specificity and virus typing by phylogenetic analysis. Molecular identification and typing of enterovirus and rhinovirus positive samples were performed with MEGA 3.1 software after ClustalW alignment and manual sequence editing with BioEdit. Phylogenetic relationships were estimated using MEGA V3.1 (neighbor-joining method by using Tajima-Nei model as estimated by using Modeltest; the *α* value used in MEGA was previously estimated directly from the data by using PAUP).

Since multiple infections are frequently detected in respiratory samples of patients with respiratory symptoms and to better clarify the pathogenetic role of picornaviruses in coinfections, all specimens positive for HRVs or HEV 109, were also assayed for the presence of other thirteen respiratory viruses, including parainfluenza viruses (PIV 1--3), influenza A and B viruses, human metapneumovirus (hMPV), human respiratory syncytial virus (hRSV), and adenoviruses, using a multiplex PCR strategy (Seeplex RV12 ACE Detection, Seegene, Rockville). Moreover, rhinovirus positive samples were also tested for human bocaviruses (hBoV), human coronaviruses (hCoV) and of the recently identified WU and KI polyomaviruses, using protocols described previously \[[@B13], [@B14]\].

3. Results and Discussion {#sec3}
=========================

Thirty seven out of the 175 samples (from 23 transplant patients) tested positive for HRV infection.

Eight of the 23 HRV positive patients were also coinfected by one or more respiratory virus ([Table 1](#tab1){ref-type="table"}); thirteen of the 23 patients were asymptomatic. Subtyping of HRV samples allowed to identify 15 HRV-A strains, 1 HRV-B strain, and 7 HRV belonging to the novel C lineage ([Table 1](#tab1){ref-type="table"} and [Figure 1](#fig1){ref-type="fig"}). In 2 out of the 7 HRV-C samples coinfections with hMPV or hCoV were identified and both were symptomatic. All of the other monoinfected HRV-C positive samples were asymptomatic. Finally, 8 out of the 15 HRV-A strains and the HRV-B strains resulted to be associated with upper respiratory symptoms such as rhinorrhea, pharingodinia or tussis, being 4 of them coinfected with other pathogens.

The novel HEV 109 could be identified in a symptomatic immunocompromised adult from a respiratory sample collected at the beginning of 2006. The tedious pharngodynia suffered by this patient in the absence of other coinfecting respiratory viruses suggests a direct pathogenetic role of this virus as speculated in initial observations \[[@B9]\]. Overall, HRV infections were common and frequently asymptomatic in this group of patients, including the majority of rhinoviruses infections due to HRV-C strains. In two patients with rhinorrhea, the HRV-C strains were detected together with other coinfecting viral pathogens. These results do not confirm the previously observed high pathogenic potential of this lineage, at least in immunocompromised hosts \[[@B6]\].

As previously documented for hMPV infections in immunocompromised patients \[[@B10], [@B11]\], not only sequential infections by different HRV subtypes were identified (patients 10 and 16), but long (up to 45 days) viral shedding was observed in four out of 23 patients (patients 1, 3, 18, and 22) not constantly associated with symptoms. Nevertheless as recently suggested, symptomatic or asymptomatic viral infections can trigger acute rejection and obliterative bronchiolitis in lung transplant recipients and warrant a continuous monitoring in immunocompromised patients, with methods able to identify an always wider panel of potential viral pathogens \[[@B15]\].
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Picornavirus positive samples. Samples\' ID (as shown in the phylogenetic tree) and time of collection are shown. Result of phylogenetic subtyping, coinfections, and respiratory symptoms are also reported.

  Patient   Sample ID   Days from transplantation   Picornavirus subtype   Coinfections    Respiratory symptoms
  --------- ----------- --------------------------- ---------------------- --------------- ----------------------
  1         ID4         15                          HRV-A2                 hMPV, hCoV      No
  ID5       25          HRV-A2                      hMPV                   No              
  ID9       35          HRV-A2                                             No              
  2         ID333       30                          HRV-C19                hMPV            Rhinorrhea
  3         ID6         −5                          HRV-A2                 hMPV, hCoV      No
  ID7       15          HRV-A2                                             No              
  ID11      35          HRV-A2                      hMPV                   No              
  4         ID26        15                          HRV-A2                                 No
  5         ID229       60                          HRV-A73/41                             Pharingodinia
  6         ID33        −30                         HRV-A65                                Rhinorrhea
  7         ID318       0                           HRV-C19                                No
  8         ID331       60                          HRV-A64/94                             No
  9         ID336       15                          HRV-C8                                 No
  10        ID19        −5                          HRV-A2                 hMPV            No
  ID40      30          HRV-A65                                            Rhinorrhea      
  ID29      60          HRV-A41                                            Rhinorrhea      
  11        ID343       30                          HRV-C19                                No
  12        ID35        −5                          HRV-A65                hMPV            Rhinorrhea
  ID25      0           HRV-A2                      hMPV, hCoV             Rhinorrhea      
  13        ID342       90                          HRV-C8                 hCoV            Rhinorrhea
  14        ID39        15                          HRV-A53                                Tussis
  ID32      30          HRV-A53                                            No              
  15        ID329       15                          HRV-C19                                No
  16        ID133       15                          HRV-A65                                No
  ID160     60          HRV-B                                              Rhinorrhea      
  17        ID286       0                           HRV-C2                                 No
  18        ID127       15                          HRV-A88                                No
  ID147     60          HRV-A88                                            Pharyngodynia   
  19        ID222       120                         HRV-A76                                No
  20        ID161       90                          HRV-A44                                No
  21        ID117       90                          HRV-A10                PIV3            Rhinorrhea
  22        ID3         −5                          HRV-A11                hMPV            No
  ID8       15          HRV-A11                     hMPV                   No              
  ID12      30          HRV-A11                     hMPV                   No              
  23        ID36        0                           HRV-A53                                No
  24        ID175       180                         HEV-109                                Pharingodinia

hMPV: human metapneumovirus; hCoV: human coronaviruses; PIV3: parainfluenza virus type 3.
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